Vor Bio

Viridiantherapeutics

This company develops antibody treatments for patients living with rare autoimmune conditions and thyroid eye disease.

Cabaletta Bio

This clinical-stage biotechnology company develops engineered T cell therapies for patients with various autoimmune diseases.

Cartesian Therapeutics

This clinical-stage biotechnology company develops mRNA cell therapies for patients with autoimmune diseases, including myasthenia gravis and myositis.

Yarrow Bioscience

This biotechnology company develops monoclonal antibody therapies for patients with autoimmune thyroid conditions, including Graves' disease and thyroid eye disease.

Ouro Medicines

This biotechnology firm develops T-cell engager therapies to treat patients living with chronic immune-mediated diseases.

Boulevard Bio

This clinical-stage biotechnology company develops multi-specific antibody therapies for patients suffering from B cell-driven autoimmune diseases.

ArgenX

This company develops and commercialises antibody-based therapies to treat patients suffering from severe autoimmune diseases and cancer.

Clim Bio

This biotechnology company develops antibody-based medicines for patients with immune-mediated diseases such as lupus and IgA nephropathy.